-

Cutera, Inc. (CUTR) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Cutera, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Cutera, Inc. (NASDAQ: CUTR) common stock between February 17, 2021 and May 9, 2023. Cutera is a medical aesthetic device company that provides equipment for beauty treatments.

For more information, submit a form, email Aaron Dumas, Jr., or give us a call at (800) 350-6003.

What is this Case About: Cutera, Inc. (CUTR) Misled Investors Regarding its Internal Controls Over Financial Reporting

According to the complaint, throughout the class period, defendants repeatedly assured investors that the Company would deliver sustainable revenue growth in the wake of the COVID-19 pandemic while concealing that the Company maintained inadequate internal control over financial reporting and significant conflicts among certain members of the Company’s senior leadership and board of directors (the “Board”).

Beginning on January 9, 2023, investors began to learn the truth. On that day, the Company announced its failure to meet revenue guidance for 2022. On February 28, 2023, Cutera disclosed its inability to timely file its annual financial report with the SEC and that it had identified material weaknesses in its internal control over financial reporting. On March 16, 2023, Cutera announced it would not meet the extended deadline to file its annual report. Then, on March 24, 2023, Cutera disclosed its non-compliance with Nasdaq Listing Rule 5250(c)(1). Beginning on April 7, 2023, the Company disclosed conflicts with Board members. Finally, on May 9, 2023, Cutera revealed disappointing financial results for the first quarter 2023 "due to execution challenges in the business." Each disclosure resulted in a decline in Cutera's stock price, which ultimately closed at $14.14 per share on May 11, 2023.

What Now: Similarly situated shareholders may be eligible to participate in the class action against Cutera, Inc. Shareholders who want to act as lead plaintiff for the class must file their papers by July 24, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against Cutera, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:CUTR

Release Summary
Cutera, Inc. (CUTR) Misled Investors Regarding its Internal Controls Over Financial Reporting
Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Stockholder Alert: Robbins LLP Informs Investors of the Fractyl Health, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ: GUTS) securities between January 13, 2025 and January 29, 2026 (the "Class Period"). Fractyl is a metabolic therapeutics company that develops therapies for the treatment of type 2 diabetes (“T2D”) and obesity.The complaint alleges that Fractyl Health misled investors regarding t...

Stockholder Alert: Robbins LLP Informs Investors of the GoDaddy Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired GoDaddy Inc. (NYSE: GDDY) common stock between September 3, 2025 and February 24, 2026 (the "Class Period"). GoDaddy is an internet domain registry, domain registrar, and web hosting company headquartered in Tempe, Arizona.The complaint alleges that GoDaddy failed to disclose to investors that it had initiate...

Stockholder Alert: Robbins LLP Informs Investors of the AEVEX Corp. Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired AEVEX Corp. (NYSE: AVEX) Class A common stock (a) between April 17, 2026 and June 4, 2026, and (b) pursuant to the Company's initial public offering ("IPO") on April 17, 2026 (the "Class Period"). AEVEX is a military technology contractor.The complaint alleges that AEVEX concealed a pre-arranged plan between...
Back to Newsroom